There is uncertainty whether current strategies for providing CVD risk scores  affect CVD events .
Providing CVD risk scores may slightly reduce CVD risk factor levels and may increase preventive medication prescribing in higher-risk people without evidence of harm .
BACKGROUND The current paradigm for cardiovascular disease ( CVD ) emphasises absolute risk assessment to guide treatment decisions in primary prevention .
Although the derivation and validation of multivariable risk assessment tools , or CVD risk scores , have attracted considerable attention , their effect on clinical outcomes is uncertain .
OBJECTIVES To assess the effects of evaluating and providing CVD risk scores in adults without prevalent CVD on cardiovascular outcomes , risk factor levels , preventive medication prescribing , and health behaviours .
Pilot study to validate a computer-based clinical decision support system for dyslipidemia treatment (HTE-DLP).
UNLABELLED Pilot study to vali date a Computerized Decision Support Systems ( CDS ) ( HTE-DLP ) for improving treatment of hyperlipidemia . METHODS HTE-DLP was programmed to offer automatic specific reminders for lipid treatment .  Seventy-seven patients with high cardiovascular risk were r and omized . 10 expert physicians in cardiovascular-risk management were recruited . We assessed number of patients at LDL < 70 mg/dl after 12 weeks of treatment . RESULTS A greater proportion of intervention group reached the LDL-C < 70 mg/ml [ 55.0 % vs 12.5 % , p = 0.003 ; OR : 3.26 IC ( 1.16 - 9.15 ) ] .  " High potency statins " and combined therapy  were used more frequently in the intervention group than the control group ( p = 0.001 ) . Seven adverse effects were documented in the intervention group and two in the control group . An acceptable relationship was observed with regard to costeffectiveness in the intervention group . Physicians expressed good agreement with HTE-DLP ( 86.1 % ) and comfortable ease-of-use ( 85 % ) . CONCLUSIONS Use of a CDSS in high-risk cardiovascular patients result ed in a significant reduction in LDL-C levels
There is uncertainty whether current strategies for providing CVD risk scores  affect CVD events .
Providing CVD risk scores may slightly reduce CVD risk factor levels and may increase preventive medication prescribing in higher-risk people without evidence of harm .
BACKGROUND The current paradigm for cardiovascular disease ( CVD ) emphasises absolute risk assessment to guide treatment decisions in primary prevention .
Although the derivation and validation of multivariable risk assessment tools , or CVD risk scores , have attracted considerable attention , their effect on clinical outcomes is uncertain .
OBJECTIVES To assess the effects of evaluating and providing CVD risk scores in adults without prevalent CVD on cardiovascular outcomes , risk factor levels , preventive medication prescribing , and health behaviours .